Immunomedics, Inc. EBITDA Margin 2010-2020 | IMMU
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Immunomedics, Inc. (IMMU) over the last 10 years. The current EBITDA margin for Immunomedics, Inc. as of June 30, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-06-30 | $0.00B | $-0.11B | -5500.00% |
| 2017-12-31 | $0.00B | $-0.04B | -1400.00% |
| 2017-09-30 | $0.00B | $-0.04B | -2100.00% |
| 2016-12-31 | $0.00B | $-0.03B | -1350.00% |
| 2016-09-30 | $0.00B | $-0.03B | -900.00% |
| 2015-12-31 | $0.00B | $-0.02B | -766.67% |
| 2015-09-30 | $0.00B | $-0.02B | -766.67% |
| 2014-12-31 | $0.00B | $-0.02B | -733.33% |
| 2014-09-30 | $0.00B | $-0.02B | -700.00% |
| 2013-12-31 | $0.01B | $-0.01B | -137.50% |
| 2013-09-30 | $0.01B | $-0.01B | -150.00% |
| 2012-12-31 | $0.00B | $-0.01B | -400.00% |
| 2012-09-30 | $0.03B | $0.02B | 53.13% |
| 2011-12-31 | $0.03B | $0.02B | 56.25% |
| 2011-09-30 | $0.00B | $-0.01B | -366.67% |
| 2010-12-31 | $0.01B | $-0.05B | -376.92% |
| 2010-09-30 | $0.02B | $-0.05B | -288.24% |
| 2009-12-31 | $0.05B | $0.02B | 32.69% |
